- Home
- ACRV vs PINE Comparison
ACRV vs PINE Comparison
Compare ACRV & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- PINE
- Stock Information
- Founded
- ACRV 2018
- PINE 2019
- Country
- ACRV United States
- PINE United States
- Employees
- ACRV N/A
- PINE N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- PINE Real Estate Investment Trusts
- Sector
- ACRV Health Care
- PINE Real Estate
- Exchange
- ACRV Nasdaq
- PINE Nasdaq
- Market Cap
- ACRV 225.8M
- PINE 239.5M
- IPO Year
- ACRV 2022
- PINE 2019
- Fundamental
- Price
- ACRV $7.87
- PINE $17.65
- Analyst Decision
- ACRV Strong Buy
- PINE Strong Buy
- Analyst Count
- ACRV 5
- PINE 8
- Target Price
- ACRV $22.60
- PINE $19.03
- AVG Volume (30 Days)
- ACRV 103.0K
- PINE 99.3K
- Earning Date
- ACRV 11-07-2024
- PINE 10-17-2024
- Dividend Yield
- ACRV N/A
- PINE 6.34%
- EPS Growth
- ACRV N/A
- PINE N/A
- EPS
- ACRV N/A
- PINE N/A
- Revenue
- ACRV N/A
- PINE $48,096,000.00
- Revenue This Year
- ACRV N/A
- PINE N/A
- Revenue Next Year
- ACRV N/A
- PINE $2.84
- P/E Ratio
- ACRV N/A
- PINE N/A
- Revenue Growth
- ACRV N/A
- PINE 5.44
- 52 Week Low
- ACRV $3.19
- PINE $14.25
- 52 Week High
- ACRV $11.90
- PINE $19.42
- Technical
- Relative Strength Index (RSI)
- ACRV 57.76
- PINE 47.82
- Support Level
- ACRV $6.87
- PINE $17.12
- Resistance Level
- ACRV $8.16
- PINE $17.99
- Average True Range (ATR)
- ACRV 0.33
- PINE 0.35
- MACD
- ACRV 0.13
- PINE -0.01
- Stochastic Oscillator
- ACRV 77.86
- PINE 41.41
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate company. It owns and operates a portfolio of single-tenant commercial properties. The company's portfolio is comprised of single-tenant retail and office properties located in or in close proximity to MSAs, growth markets and other markets in the United States. Their portfolio consists of One thirty eight net leased properties located in Hundred and four markets in thirty five states. The majority of the firm's revenue includes rental revenue derived from the ownership and leasing of property.